妊娠早期接受异烟肼预防性治疗的HIV感染女性不良妊娠结局
这项结核预防试验的预设二次分析比较了妊娠早期暴露于9个月异烟肼预防性治疗(IPT)与未暴露孕妇的不良妊娠结局。128例已知妊娠结局者中,IPT暴露39例、未暴露89例;调整入组协变量后IPT与复合不良结局相关(aRR 1.98;95%CI 1.15, 3.41),但调整妊娠结局时协变量后关联减弱(aRR 1.47;95%CI 0.84, 2.55)。
要点
- 妊娠早期IPT暴露与复合不良结局相关,调整入组协变量后aRR 1.98(95%CI 1.15, 3.41)。
- 调整妊娠结局时协变量(含ART)后关联减弱,aRR 1.47(95%CI 0.84, 2.55)。
- IPT与早产(RR 0.87;95%CI 0.32-2.42)和低出生体重(RR 1.01;95%CI 0.29, 3.56)无显著关联。
核心结论
- 妊娠早期IPT暴露与胎儿死亡风险增加近两倍相关,主要为自然流产,但调整包括ART使用在内的妊娠结局时协变量后关联减弱。
- 需进一步研究以指导结核预防指南。
研究设计与样本
- 结核预防试验的预设二次分析,比较妊娠期间(IPT暴露)或之后(未暴露)怀孕且被分配至9个月IPT的参与者。
- 共128例已知妊娠结局,其中IPT暴露39例、未暴露89例。
主要发现
- 妊娠结局时,IPT暴露组ART使用率(79%)低于未暴露组(98%)。
- 总体上29例妊娠发生复合不良结局(25例自然流产、2例死产和2例异位妊娠),15例早产,10例低出生体重。
- 调整入组协变量后,IPT与复合不良结局相关(aRR 1.98;95%CI 1.15, 3.41)。
- 调整妊娠结局时协变量后,关联减弱(aRR 1.47;95%CI 0.84, 2.55)。
- IPT与早产(RR 0.87;95%CI 0.32-2.42)或低出生体重(RR 1.01;95%CI 0.29, 3.56)无显著关联。
局限性
- 原文结论指出需进一步研究以指导结核预防指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Isoniazid preventive therapy (IPT) is recommended for tuberculosis prevention yet data on the safety of first-trimester pregnancy exposure are limited. METHODS: Planned secondary analysis in a TB prevention trial of adverse pregnancy outcomes among participants assigned to 9-month IPT who became pregnant during (IPT-exposed) or after (unexposed) IPT. Regression models compared binary outcomes of a composite adverse outcome (any non-live birth, excluding induced abortion); preterm delivery <37 weeks; and low birth weight <2500 g) among exposure groups. Models were adjusted for latent TB infection, maternal age, CD4 count, and antiretroviral therapy (ART). RESULTS: In total, 128 participants had a known pregnancy outcome; 39 IPT-exposed and 89 unexposed. At pregnancy outcome, ART use was lower in IPT-exposed (79%) than unexposed women (98%). Overall, 29 pregnancies ended in a composite adverse outcome (25 spontaneous abortions, 2 stillbirths and 2 ectopic pregnancies), 15 preterm deliveries, and 10 infants with low birth weight. IPT was associated with the composite adverse outcome adjusting for covariates at enrollment (adjusted relative risk [aRR] 1.98; 95% confidence interval [CI] 1.15, 3.41), but the effect was attenuated when adjusted for covariates at pregnancy outcome (aRR 1.47; 95% CI .84, 2.55); IPT was not associated with preterm delivery (relative risk [RR] 0.87; 95% CI .32-2.42) or low birth weight (RR 1.01; 95% CI .29, 3.56). CONCLUSIONS: First-trimester IPT exposure was associated with nearly two-fold increased risk of fetal demise, mostly spontaneous abortion, though the association was attenuated when adjusted for covariates proximal to pregnancy outcome including ART use. Further study is needed to inform TB prevention guidelines.
引用
- Gupta A, Hughes MD, Cruz JL, et al. Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester. Clin Infect Dis. 2024. PMID: 37768207. doi:10.1093/cid/ciad583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。